Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 47,293 shares at $105.88 ($5.0M) on 2022-05-04, disclosed to the SEC on 2022-05-05.
Seasonal sale ($5.0M) by CVP, Critical Care — this insider has traded EW in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.18 | 9,155 | $954K | 19.2% |
| 2 | $104.18 | 9,155 | $954K | 19.2% |
| 3 | $105.10 | 10,449 | $1.1M | 22.1% |
| 4 | $105.10 | 10,449 | $1.1M | 22.1% |
| 5 | $105.88 | 3,796 | $402K | 8.1% |
| 6 | $105.88 | 3,796 |
| $402K |
| 8.1% |
| 7 | $105.93 | 493 | $52K | 1.1% |
| Total | $104.88 avg | 47,293 | $5.0M | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |